CoChat

Declining efficacy in controlled trials of antidepressants: effects of placebo dropout

Open access
Schalkwijk, Stein, Undurraga, Juan, Tondo, Leonardo, Baldessarini, Ross J. · 2014 · The International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Drug-placebo differences (effect-sizes) in controlled trials of antidepressants for major depressive episodes have declined for several decades, in association with selectively increasing clinical improvement associated with placebo-treatment. As these trends require adequate explanation, we tested the hypothesis that decreasing trial-dropout rates may be an important contributor. We gathered reports of peer-reviewed, placebo-controlled trials of antidepressants (1980-2011) by computerized literature searching, and applied meta-analysis, meta-regression and multiple linear regression methods to evaluate associations of dropout rates and other factors of interest, to reporting year and reported efficacy [standardized mean drug-placebo difference (SMD) as Hedges' g-statistic]. In 56 trials meeting inclusion and exclusion criteria, we confirmed significant overall efficacy of antidepressants but declining drug-placebo contrasts over the past three decades. Among other changes, there was a corresponding increase in placebo-associated improvement with a decline in placebo-dropout rate, mainly for lack of efficacy. These effects were found only when last-observation-carried-forward (LOCF) analyses were used. Other trial-design and subject factors, including drug-responses and drug-dropout rates, were much less associated with efficacy. We propose that declining placebo-dropout rates ascribed to inefficacy combined with use of LOCF analyses led to increasing improvement in placebo-arms that contributed to declining antidepressant-placebo contrasts in controlled treatment trials since the 1980s.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1461145714000224

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 46 references

Research works printed but not linked: 3

  1. 2005, Int J Epidemiol, 34, 79
  2. 2008, Schizophrenia Bull, 34, 286
  3. 2003, J Nerv Ment Dis, 191, 211

Cited by

See all 37

Metadata

Authors
Schalkwijk, S., Undurraga, J., Tondo, L., & Baldessarini, R. J.
Affiliations
  • Harvard University (US)
  • Universidad del Desarrollo (CL)
Corresponding author
Baldessarini, Ross J.
Venue
The International Journal of Neuropsychopharmacology
Published
2014-03-13
Volume
17
Issue
08
Pages
1343-1352
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2005455004
Cited by
34
References
46
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 1 · 2017: 7 · 2016: 2 · 2015: 2
FWCI
0.36
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
  • National Institutes of Health (UL1TR000170)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
antidepressants, major depressive episode, placebo response
MeSH terms
Antidepressive Agents, Major Depressive Disorder, Humans, Patient Dropouts, Placebo Effect, Linear Models, Treatment Outcome, Controlled Clinical Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. https://app.cochat.ai/papers/10.1017/s1461145714000224
The paper
Schalkwijk, S., Undurraga, J., Tondo, L., & Baldessarini, R. J. (2014). Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145714000224

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.